SynOx Therapeutics Limited
SynOx Therapeutics Limited provides life-improving options to address the unmet clinical needs of people living with (TGCT)Tenosynovial giant cell tumors and other macrophage-mediated diseases, enabling patients to have a best-in-class treatment option that can significantly improve their quality of life.
$35M
Latest Funding
Debt Financing
Latest Funding Stage
2024-04-30
Funding Date
13
Employees
Ireland
Location
Dublin, Dublin
City & State
Sales-Ready Summary
SynOx Therapeutics recently secured $35M in debt financing, indicating new budget allocation; with a tech stack including WordPress and PHP, they could benefit from services optimizing website performance and security.
Key Contacts
Open Positions
View Careers PageSimilar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.